BIO Asia–Taiwan 2023 亞洲生技大會

BIO Asia–Taiwan 2023 亞洲生技大會




Company Info

Name /Advpharma, Inc.

Address /6F, No.90, Sec.1, Xintai 5th Road, Xizhi District, New Taipei City, Taiwan (22102)

Website /




Email /

Telephone /+886-2-2696-3922

Fax /

Mobile /

Company Type


About the Company

Advpharma, Inc., a subsidiary of Standard Chem. & Pharmaceutical company in Taiwan (, was founded in December 1999. We focus on development of innovative molecular assays for diagnosis and prognosis of cancer diseases. Highly specific mRNA markers, NeoPlasMarker® (NPM®), are identified and clinically validated by analysis of tumor tissues, liquid biopsies, and pleural effusions, in cooperation with hospitals for over ten years. NPM® assay is currently provided as services for prediction of clinical outcome of patients with colorectal cancer or with non-small cell lung cancer. Further, NPM® assay could sensitively detect the malignant cells in pleural effusion.

Brief Description of main products or services

NeoPlasMarker® (NPM®) assay is an innovative platform to assess dynamic status of patients with cancer disease. Highly cancer-specific gene signatures are clinically validated with tumor tissues, liquid biopsies, and pleural effusions. Analytical services have been providing for clinical organizations.

  1. NPM® assay for assessment of clinical outcome of cancer patients
    • Provide precise and personal information of status of patients, such as therapeutic response, early detection of distant metastasis, and recurrence.
    • Advantages: low invasive and multiple samplings of peripheral blood for analysis
    • High performance quality : sensitivity, specificity, and accuracy 80~85%;
    • NPM® panels for clinical service items:
      NPM®-CR assay: colorectal cancer
      NPM®-LC assay: non-small cell lung cancer
  2. NPM®-mPE assay for detection of malignant pleural effusion (MPE)
    Provide the information of cancer-associated gene signature of cells, which are cytologically or pathologically negative (unmet need).

These assays allow early detection of metastatic cancer cells and physicians could arrange proper treatment to prolong the survival time of patients. Cooperation, license, or Joint Venture is welcomed.

Contact Person


Email /

Phone /